Improving outcomes for youth with type 2 diabetes by addressing social needs
Official title: Optimizing Navigation for Wellness And Resources Utilization in Youth With Type 2 Diabetes
Run by University of Pittsburgh · NCT07216118 · Data updated 2026-11-12
This project will try different ways to connect teens and young adults with type 2 diabetes and their families to social supports and resources to help with diabetes care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 13 Years and up |
| Sex | All |
| Enrollment | 104 (estimated) |
| Sponsor | University of Pittsburgh Academic / other |
| Locations | 1 site (Pittsburgh, Pennsylvania) |
| Status | Recruiting |
| Started | April 21, 2026 |
| Main results expected | April 2028 |
| Study ends | July 2028 |
| Registry record updated | April 27, 2026 |
| Trial ID | NCT07216118 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adolescents aged 13–22 with a diagnosis of type 2 diabetes who receive care at UPMC Children's Hospital of Pittsburgh and can participate alongside a consenting caregiver.
✕Probably not a fit
Patients who do not speak English or who are not followed at the recruiting clinic are unlikely to benefit from this program as designed.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This pilot enrolls adolescent-caregiver dyads followed at UPMC Children's Hospital of Pittsburgh and tests several strategies to address health-related social needs, including tailored resources, universal empowerment materials, text messaging, and community health workers. Participants continue routine diabetes clinic visits, complete surveys and interviews, and are connected to community organizations as needed. The study collects process data and participant feedback to measure feasibility, acceptability, and implementation reliability. Results will guide larger programs and trials aimed at reducing social barriers to diabetes management in youth.
Why it matters
Potential benefit: If successful, these strategies could make it easier for young people with type 2 diabetes to obtain social supports that improve daily diabetes management and health outcomes.
How similar studies have gone: Similar approaches using community health workers, tailored resources, and text messaging have shown promise in adults and some pediatric settings, but they are less well studied specifically in adolescents with type 2 diabetes.
Who can join: the full rules
Show full inclusion / exclusion criteria
Adolescent-Caregiver Dyads will be recruited together. Adolescent Inclusion Criteria: * Age 13 to 22 years old * known diagnosis of type 2 diabetes * followed clinically at UPMC Children's Hospital of Pittsburgh * able to provide assent/consent Caregiver Inclusion Criteria: * Adult (18 years or older) identifying as a primary caretaker of an adolescent or young adult with type 2 diabetes * Has an adolescent/young adult who agrees to participate in the study * able to provide consent Exclusion Criteria: * Inability to complete study questionnaires in English
Where it's running
-
UPMC Children's Hospital of Pittsburgh
Pittsburgh, Pennsylvania, United States Recruiting
Study contacts
- Principal investigator: Mary Ellen Vajravelu, MD MSHP — University of Pittsburgh
- Study coordinator: Mary Ellen Vajravelu, MD MSHP
- Email: maryellen.vajravelu@pitt.edu
- Phone: 412-692-6533
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Acute Blood Flow Restriction Walking in Type 2 Diabetes
This study tests whether adding blood flow restriction to treadmill walking affects immune cells in adults with type 2 diabetes.
-
Continuous Glucose Monitoring in Type 2 Diabetes Not on Insulin
This study tests whether using a continuous glucose monitoring system helps people with type 2 diabetes who aren’t using insulin to improve blood sugar control and quality of life.
-
Differentiating heart disease in autoimmune vs. type 2 diabetes
This study tests whether adult-onset autoimmune diabetes (AID/LADA) and type 2 diabetes (T2D) differ in how diabetic heart disease develops, using advanced heart imaging in people with AID, T2D, and healthy controls.
-
Lifestyle Metabotype Study B: Understanding Personalized Glucose Responses
This study tests how lifestyle, metabolism, and brain energy use relate to each person’s blood sugar response after meals, across people with and without prediabetes or type 2 diabetes.
-
Lifestyle Metabotype Study: How Daily Habits Shape Blood Sugar
This observational study tests whether personal lifestyle and biological factors can predict how a person’s blood sugar responds after meals.
-
Switching to Zenagamtide From Tirzepatide in Adults With Overweight or Obesity With or Without Type 2 Diabetes
This study tests whether adults who are overweight or have obesity (with or without type 2 diabetes) can switch from tirzepatide to a new treatment called zenagamtide to find a tolerable dose.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.